Anti-NCOA1/ F-SRC-1/ KAT13A monoclonal antibody

Anti-NCOA1/ F-SRC-1/ KAT13A antibody for FACS & in-vivo assay

Target products collectionGo to NCOA1/NCOA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2212-Ab-1/ GM-Tg-hg-MP2212-Ab-2Anti-Human NCOA1 monoclonal antibodyHuman
GM-Tg-rg-MP2212-Ab-1/ GM-Tg-rg-MP2212-Ab-2Anti-Rat NCOA1 monoclonal antibodyRat
GM-Tg-mg-MP2212-Ab-1/ GM-Tg-mg-MP2212-Ab-2Anti-Mouse NCOA1 monoclonal antibodyMouse
GM-Tg-cynog-MP2212-Ab-1/ GM-Tg-cynog-MP2212-Ab-2Anti-Cynomolgus/ Rhesus macaque NCOA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2212-Ab-1/ GM-Tg-felg-MP2212-Ab-2Anti-Feline NCOA1 monoclonal antibodyFeline
GM-Tg-cang-MP2212-Ab-1/ GM-Tg-cang-MP2212-Ab-2Anti-Canine NCOA1 monoclonal antibodyCanine
GM-Tg-bovg-MP2212-Ab-1/ GM-Tg-bovg-MP2212-Ab-2Anti-Bovine NCOA1 monoclonal antibodyBovine
GM-Tg-equg-MP2212-Ab-1/ GM-Tg-equg-MP2212-Ab-2Anti-Equine NCOA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2212-Ab-1/ GM-Tg-hg-MP2212-Ab-2; GM-Tg-rg-MP2212-Ab-1/ GM-Tg-rg-MP2212-Ab-2;
GM-Tg-mg-MP2212-Ab-1/ GM-Tg-mg-MP2212-Ab-2; GM-Tg-cynog-MP2212-Ab-1/ GM-Tg-cynog-MP2212-Ab-2;
GM-Tg-felg-MP2212-Ab-1/ GM-Tg-felg-MP2212-Ab-2; GM-Tg-cang-MP2212-Ab-1/ GM-Tg-cang-MP2212-Ab-2;
GM-Tg-bovg-MP2212-Ab-1/ GM-Tg-bovg-MP2212-Ab-2; GM-Tg-equg-MP2212-Ab-1/ GM-Tg-equg-MP2212-Ab-2
Products NameAnti-NCOA1 monoclonal antibody
Formatmab
Target NameNCOA1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NCOA1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NCOA1/ F-SRC-1/ KAT13A VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2212
    Target NameNCOA1
    Gene ID8648,17977,313929,718524,475684,101094588,525346,100056042
    Gene Symbol and SynonymsbHLHe42,bHLHe74,F-SRC-1,KAT13A,mNRC-1,NCoA-1,NCOA1,NRC-1,RIP160,SRC-1,SRC-a,SRC1
    Uniprot AccessionQ15788
    Uniprot Entry NameNCOA1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000084676
    Target ClassificationTumor-associated antigen (TAA)

    The target: NCOA1, gene name: NCOA1, also named as F-SRC-1, KAT13A, RIP160, SRC1, bHLHe42, bHLHe74. The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and contains a nuclear localization signal, as well as bHLH and PAS domains. The product of this gene binds nuclear receptors directly and stimulates the transcriptional activities in a hormone-dependent fashion. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.